32nd week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200246224 | MEDICATION CONTAINER WITH MEDICATION-RELATED INFORMATION AND METHOD FOR FACILITATING MEDICATION-RELATED INFORMATION | 2020-08-06 |
20200246225 | DRUG DISPENSER | 2020-08-06 |
20200246226 | METHOD FOR PRODUCING CAPSULES COMPRISING AT LEAST ONE WATER-SOLUBLE OR HYDROPHILIC SUBSTANCE, AND RESULTING CAPSULES | 2020-08-06 |
20200246227 | Aqueous Perfume Compositions | 2020-08-06 |
20200246228 | METHOD AND PRODUCT FOR PRODUCING FORMULATIONS CONTAINING CERAMIDE | 2020-08-06 |
20200246229 | POWDER CONTAINING WATER-BASED COMPOSITION AND EXTERNAL SKIN PREPARATION | 2020-08-06 |
20200246230 | OIL-IN-WATER EMULSION COMPOSITION, PREPARATION METHOD THEREFOR AND PRODUCT | 2020-08-06 |
20200246231 | WATER-IN-OIL EMULSION COMPOSITION | 2020-08-06 |
20200246232 | Nail Varnish Composition Containing Embossed Effect Pigments and Surface-Modified Embossed Effect Pigments | 2020-08-06 |
20200246233 | ORAL CARE PRODUCT | 2020-08-06 |
20200246234 | COSMETIC | 2020-08-06 |
20200246235 | An Antimicrobial Composition | 2020-08-06 |
20200246236 | USE OF 1,3 DIGLYCERIDE IN A TOPICAL COMPOSITION FOR COUNTERING THE WEAKENING OF THE SKIN BARRIER | 2020-08-06 |
20200246237 | METHOD OF ENHANCING HAIR GROWTH | 2020-08-06 |
20200246238 | PROCESS FOR DYEING KERATIN FIBRES USING AT LEAST ONE PARTICULAR AZINIUM DYE AND AT LEAST ONE FLUORESCENT DYE | 2020-08-06 |
20200246239 | POWDER HAIR DYE COMPOSITION | 2020-08-06 |
20200246240 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | 2020-08-06 |
20200246241 | COSMETIC COMPOSITION FOR BLOCKING FINE DUST | 2020-08-06 |
20200246242 | Personal Care Compositions Including Naringin:zinc Complexes and Methods for the Same | 2020-08-06 |
20200246243 | FAST-ACTING MICELLE NANOPARTICLE AND COSMETIC COMPOSITION COMPRISING SAME | 2020-08-06 |
20200246244 | MOUSSE COMPOSITION | 2020-08-06 |
20200246245 | EMULSIFIER SYSTEM, PERSONAL CARE PRODUCT, METHOD AND USE | 2020-08-06 |
20200246246 | COSMETIC | 2020-08-06 |
20200246247 | COSMETIC COMPOSITIONS CONTAINING AN ALKOXYSILANE AND A SILSESQUIOXANE RESIN | 2020-08-06 |
20200246248 | COSMETIC | 2020-08-06 |
20200246249 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | 2020-08-06 |
20200246250 | COMPOSITIONS OF MARINE BOTANICALS TO PROVIDE NUTRITION TO AGING AND ENVIRONMENTALLY DAMAGED SKIN | 2020-08-06 |
20200246251 | COSMETIC COMPOSITIONS AND METHODS | 2020-08-06 |
20200246252 | TOPICAL COMPOSITION COMPRISING A SMALL RNA TIGER LILY EXTRACT AND METHOD OF COSMETIC CARE TO REDUCE SKIN SIGNS OF AGING | 2020-08-06 |
20200246253 | PHARMACEUTICAL FORMULATION | 2020-08-06 |
20200246254 | PARENTERAL DOSAGE FORM OF DILTIAZEM | 2020-08-06 |
20200246255 | IMPLANTABLE DEPOTS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | 2020-08-06 |
20200246256 | METHOD OF PROVIDING BIRTH CONTROL | 2020-08-06 |
20200246257 | METHOD OF PROVIDING BIRTH CONTROL | 2020-08-06 |
20200246258 | METHOD OF PROVIDING BIRTH CONTROL | 2020-08-06 |
20200246259 | METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTONS TYROSINE KINASE | 2020-08-06 |
20200246260 | Polyiodide Resin Powder for Use with Medical Devices | 2020-08-06 |
20200246261 | PHARMACEUTICAL COMPOSITION OF ORAL SUSPENSION OF IMMUNOSUPPRESSIVE AGENTS | 2020-08-06 |
20200246262 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | 2020-08-06 |
20200246263 | STABLE LIQUID COMPOSITIONS OF PEMETREXED | 2020-08-06 |
20200246264 | POLYMERIC DRUG DELIVERY SYSTEMS FOR TREATMENT OF DISEASE | 2020-08-06 |
20200246265 | LIPOSOMES COMPRISING POLYMER-CONJUGATED LIPIDS AND RELATED USES | 2020-08-06 |
20200246266 | PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE | 2020-08-06 |
20200246267 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | 2020-08-06 |
20200246268 | CPZEN COMPOSITIONS AND USES | 2020-08-06 |
20200246269 | Protease Cleavage Site Peptides as an HIV Vaccine | 2020-08-06 |
20200246270 | FORMULATION HAVING CONTROLLED, DELAYED RELEASE OF ACTIVE INGREDIENT | 2020-08-06 |
20200246271 | ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF | 2020-08-06 |
20200246272 | PHARMACEUTICAL CARRIER DESIGN | 2020-08-06 |
20200246273 | DRUG DELIVERY SYSTEMS CONTAINING OXIDIZED CHOLESTEROLS | 2020-08-06 |
20200246274 | GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY | 2020-08-06 |
20200246275 | COMBINATION THERAPY COMPRISING NANOPARTICLES OF A TAXANE AND ALBUMIN WITH ABT-263 IN METHODS FOR TREATING CANCER | 2020-08-06 |
20200246276 | TRANSDERMAL DELIVERY SYSTEM INCLUDING AN EMULSIFIER | 2020-08-06 |
20200246277 | Composition For Alleviating, Preventing Or Treating Premenstrual Syndrome, Containing, As Active Ingredient, Pinitol, D-Chiro-Inositol Or Analog Compound Thereof | 2020-08-06 |
20200246278 | INJECTABLE DIETHYLSTILBESTROL NANOSUSPENSION FORMULATION | 2020-08-06 |
20200246279 | Methods For The Treatment Of Depression | 2020-08-06 |
20200246280 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2020-08-06 |
20200246281 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same | 2020-08-06 |
20200246282 | Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase | 2020-08-06 |
20200246283 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PANCREATIC CANCER, CONTAINING GOSSYPOL AND PHENFORMIN AS ACTIVE INGREDIENTS | 2020-08-06 |
20200246284 | Use of Ureidomustine (BO-1055) in Cancer Treatment | 2020-08-06 |
20200246285 | SMALL MOLECULE INHIBITORS OF SLC25A1 | 2020-08-06 |
20200246286 | NOVEL IMAGING COMPOSITION AND USES THEREOF | 2020-08-06 |
20200246287 | PYRIMETHAMINE-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF | 2020-08-06 |
20200246288 | OIL PALM PHENOLICS COMPOSITION FOR THE PROTECTION OF HUMANS, ORGANS, CELLS AND TISSUES AGAINST THE INJURIOUS EFFECTS OF EXPOSURE TO IONIZING RADIATION | 2020-08-06 |
20200246289 | FLUORENONE COMPOUND FOR THE TREATMENT OF GOUT | 2020-08-06 |
20200246290 | DRUG COMBINATION WITH ANTITUMOR EFFECTS | 2020-08-06 |
20200246291 | ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH | 2020-08-06 |
20200246292 | PHARMACEUTICAL COMPOSITIONS AND THE TREATMENT OF OVERACTIVE BLADDER | 2020-08-06 |
20200246293 | USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION | 2020-08-06 |
20200246294 | Fixed Dose Combination Formulations for Treating Pain | 2020-08-06 |
20200246295 | SUBSTITUTED BISPHENYL BUTANOIC ESTER DERIVATIVES AS NEP INHIBITORS | 2020-08-06 |
20200246296 | COMPOSITIONS AND METHODS FOR TREATING ANXIETY-RELATED DISORDERS | 2020-08-06 |
20200246297 | LIQUID PHARMACEUTICAL FORMULATIONS OF TETRAIODOTHYRONINE | 2020-08-06 |
20200246298 | Composition for Preventing or Treating Asthma Comprising Fatty Acid as Active Ingredient | 2020-08-06 |
20200246299 | EMULSION AND EMULSION PRECONCENTRATE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND USES THEREOF | 2020-08-06 |
20200246300 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2020-08-06 |
20200246301 | COMPOSITIONS FOR THE TREATMENT OF DRY EYE AND METHODS OF USE THEREOF | 2020-08-06 |
20200246302 | LONG-ACTING PRODRUGS OF RASAGILINE, PREPARING METHODS AND USES THEREOF | 2020-08-06 |
20200246303 | Neurodevelopmental Disorder Therapy | 2020-08-06 |
20200246304 | Composition For Preventing Or Treating TNF-Related Diseases, Containing Novel Derivative As Active Ingredient, And Method For Inhibiting TNF Activity By Using Same | 2020-08-06 |
20200246305 | APPLICATION OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL TRPV3 IN DEVELOPING DRUG FOR PREVENTING OR TREATING PSORIASIS | 2020-08-06 |
20200246306 | TRANSMUCOSAL DELIVERY OF TOCOTRIENOL | 2020-08-06 |
20200246307 | COMPOSITION FOR INHIBITING A GROWTH OF CANCER STEM CELLS COMPRISING CICLESONIDE | 2020-08-06 |
20200246308 | SYNERGISTIC COMBINATIONS OF UROLITHINS A AND B FOR IMPROVING COGNITIVE CAPACITY OR COGNITIVE FUNCTION | 2020-08-06 |
20200246309 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PRURITUS, CONTAINING PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT, AND SCREENING METHOD FOR DETECTING SAME | 2020-08-06 |
20200246310 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRESBYOPIA, MYDRIASIS, AND OTHER OCULAR DISORDERS | 2020-08-06 |
20200246311 | NASAL DECONGESTANT COMPOSITIONS COMPRISING DEXPANTHENOL AND SODIUM HYALURONATE | 2020-08-06 |
20200246312 | ORAL BENDAMUSTINE FORMULATIONS | 2020-08-06 |
20200246313 | METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER | 2020-08-06 |
20200246314 | DYSLIPIDEMIA THERAPEUTIC AGENT | 2020-08-06 |
20200246315 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | 2020-08-06 |
20200246316 | METHODS OF TREATING POST-SURGICAL PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC AGENT | 2020-08-06 |
20200246317 | METHODS OF TREATING DIABETIC NEUROPATHY WITH A THIAZOLINE ANTI-HYPERALGESIC AGENT | 2020-08-06 |
20200246318 | METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC | 2020-08-06 |
20200246319 | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT-RELATED DISEASE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT-RELATED DISEASE PREPARED BY THE SAME | 2020-08-06 |
20200246320 | AMLODIPINE FORMULATIONS | 2020-08-06 |
20200246321 | LOCALLY-INDUCED ADIPOSE TISSUE BROWNING BY MICRONEEDLE PATCH FOR OBESITY TREATMENT | 2020-08-06 |
20200246322 | METHOD FOR TREATING GLUTEN-RELATED ALLERGIES AND INTOLERANCE ISSUES WITH LOPERAMIDE | 2020-08-06 |
20200246323 | Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors | 2020-08-06 |